Antimicrobial Agents and Chemotherapy · 1985 · 43 citations · 23 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyClinical PharmacologyInfectious Disease PharmacotherapyBacteremia ManagementCombination Antimicrobial TherapyDefinitive Antimicrobial TherapyPneumonia PharmacotherapyCombination Therapy EvaluationInpatient Pneumonia TreatmentPneumonia Antibiotic Therapy
A prospective, randomized study was undertaken to compare the efficacy and safety of ceftazidime with those of a combination of ticarcillin and tobramycin in the treatment of 40 nonneutropenic patients with pneumonia or bacteremia. Altogether, 93% of the patients receiving ceftazidime for pneumonia were cured, and 87% of those with bacteremia responded favorably. Of the subjects who were treated with ticarcillin and tobramycin ceftazidime developed significant superinfection, and one individual treated with the aminoglycoside and carboxypenicillin developed reversible azotemia. Ceftazidime appears to be as efficacious as the ticarcillin-tobramycin combination and is probably safer with regard to oto-and nephrotoxicity; however, superinfections did occur more frequently in the group treated with ceftazidime.
23
William R. McCabe · Archives of Internal Medicine · 1962 · 1.4K citations
Controlled Comparison of Amikacin and Gentamicin
Craig R. Smith, Kenneth L. Baughman, Corwin Q. Edwards et al. · New England Journal of Medicine · 1977 · 260 citations
James E. Pennington, Herbert Y. Reynolds, Paul P. Carbone · The American Journal of Medicine · 1973 · 182 citations
James J. Rahal · Medicine · 1978 · 133 citations